ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
120.766,57
-1,09%
S&P 500
5.974,07
0,73%
US Dollar vs BRL
6,1943
-0,02%
Bitcoin
94.431,36
-0,27%
Brent Oil
72,745
0,06%
As Melhores Corretoras Online
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. AMEX
  6. Scorpius Holdings Inc (SCPX)

  7. Scorpius Holdings Inc (SCPX) Notícias

SCPX

Scorpius (SCPX)

Scorpius Holdings Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:AMEX:SCPX
DataHoraFonteTítuloCódigoCompanhia
23/12/202418:15Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]AMEX:SCPXScorpius Holdings Inc
23/12/202402:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessAMEX:SCPXScorpius Holdings Inc
18/12/202408:09Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933AMEX:SCPXScorpius Holdings Inc
11/12/202418:05Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesAMEX:SCPXScorpius Holdings Inc
09/12/202419:26Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsAMEX:SCPXScorpius Holdings Inc
06/12/202408:00Edgar (US Regulatory)Form 8-K - Current reportAMEX:SCPXScorpius Holdings Inc
19/11/202409:30GlobeNewswire Inc.Scorpius Holdings Launches Scorpius Ventures to Support U.S. Biotech Innovation through Flexible Equity-Based Onshoring ModelAMEX:SCPXScorpius Holdings Inc
14/11/202418:19Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:SCPXScorpius Holdings Inc
14/11/202418:15GlobeNewswire Inc.Scorpius Holdings Reports Third Quarter 2024 Results, Highlighting Strategic Partnerships, Cost Savings, and Progress Toward ProfitabilityAMEX:SCPXScorpius Holdings Inc
04/11/202409:30GlobeNewswire Inc.Scorpius Holdings Announces Collaboration with Celltheon Corporation, a U.S.-Based Cell Line Development Company; First Client Signed Under New Partnership AgreementAMEX:SCPXScorpius Holdings Inc
31/10/202408:30GlobeNewswire Inc.Scorpius Holdings Announces Implementation of New Cost Savings Measures Expected to Save Over $2 Million AnnuallyAMEX:SCPXScorpius Holdings Inc
22/10/202409:00GlobeNewswire Inc.Scorpius Holdings Announces Partnership with U.S. Biotech CompanyAMEX:SCPXScorpius Holdings Inc
02/10/202409:00GlobeNewswire Inc.Scorpius Holdings Selected to Join Medical CBRN Defense Consortium to Advance Medical Countermeasures Against Chemical, Biological, Radiological, and Nuclear ThreatsAMEX:SCPXScorpius Holdings Inc
30/09/202409:00GlobeNewswire Inc.Scorpius Holdings Announces Contract with Premier Clinical-Stage Biotech Company; Opens Door to Future GMP Manufacturing OpportunitiesAMEX:SCPXScorpius Holdings Inc
26/09/202417:05Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsAMEX:SCPXScorpius Holdings Inc
12/09/202409:00GlobeNewswire Inc.Scorpius Holdings Commends the U.S. House of Representatives’ Passage of the BIOSECURE ActAMEX:SCPXScorpius Holdings Inc
09/09/202409:30GlobeNewswire Inc.Scorpius Selected for Rapid Response Partnership Vehicle (RRPV) to Accelerate Medical Countermeasure Development in Support of BARDAAMEX:SCPXScorpius Holdings Inc
26/08/202409:00GlobeNewswire Inc.Scorpius Holdings CEO Provides Corporate Update; Highlights Expanding Sales Pipeline, Enhanced Manufacturing Capabilities, and Path Toward Positive Cash FlowAMEX:SCPXScorpius Holdings Inc
20/08/202410:15GlobeNewswire Inc.Scorpius Holdings Achieves 16% Year-Over-Year Increase in Revenue for the Second Quarter of 2024AMEX:SCPXScorpius Holdings Inc
19/08/202414:08GlobeNewswire Inc.Scorpius Holdings, Inc. Announces Closing of Public OfferingAMEX:SCPXScorpius Holdings Inc
16/08/202417:41Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]AMEX:SCPXScorpius Holdings Inc
16/08/202410:50GlobeNewswire Inc.Scorpius Holdings, Inc. Announces Pricing of Public OfferingAMEX:SCPXScorpius Holdings Inc
15/08/202417:00Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBAMEX:SCPXScorpius Holdings Inc
09/08/202416:38GlobeNewswire Inc.Scorpius Holdings, Inc. Provides Update on its Previously Announced Public OfferingAMEX:SCPXScorpius Holdings Inc
30/07/202409:00GlobeNewswire Inc.Scorpius Holdings Announces Removal of NYSE American Trading Suspension; Expected to Resume Normal Trading on August 2, 2024AMEX:SCPXScorpius Holdings Inc
24/07/202409:30GlobeNewswire Inc.Scorpius Holdings Set to Launch First Mammalian cGMP Campaign at San Antonio Facility in the 2024 3rd QuarterAMEX:SCPXScorpius Holdings Inc
18/07/202409:30GlobeNewswire Inc.Scorpius Holdings Successfully Executes First cGMP Microbial Batches at San Antonio FacilityAMEX:SCPXScorpius Holdings Inc
17/07/202417:30GlobeNewswire Inc.Scorpius Holdings Announces Reverse Stock SplitAMEX:SCPXScorpius Holdings Inc
17/06/202418:24Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersAMEX:SCPXScorpius Holdings Inc
17/06/202418:22Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsAMEX:SCPXScorpius Holdings Inc
 Apresentando as notícias mais relevantes sobre:AMEX:SCPX

Seu Histórico Recente

TSXV
ACS
Archon Minerals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados